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1. Introduction     
Mimicking Nature and designing bioinspired materials represents a promising way to reach 
technological innovations in many interdisciplinary scientific fields, since biological 
materials exhibit a high degree of sophistication, hierarchical organisation, hybridisation, 
efficiency, resistance and adaptability. These properties, which biogenic materials have 
achieved through specific building principles selected by evolution, can only be partially 
possessed in man-made materials by present synthetic processes. For this reason Nature is a 
school for material scientists, in view of the fact that living organisms can produce different 
amazing high-performance materials (Sanchez et al., 2005). 
Nature produces soft and hard materials exhibiting remarkable functional properties by 
controlling the hierarchical assembly of simple molecular building blocks from the nano- to 
the macro-scale. Biogenic materials are nucleated in defined nano–micro dimensioned sites 
inside the biological environments, in which chemistry can be spatially controlled (Mann et 
al., 1993; Weiner & Addadi 1997). The spatial delimitation is essential to biological 
mechanisms for controlling the size, shape and structural organisation of biomaterials. 
Recently, with the development of nanotechnology, this strategy employing natural material 
genesis has attracted a lot of attention in designing bioinspired materials such as polymeric 
micelles, nanoparticles, dendrimers and nanocrystals synthesised in nanoscale dimensions 
(Sarikaya et al., 2003; Tamerler & Sarikaya 2007; Vriezema et al., 2005). 
One of the most exciting and economical rewarding research areas of materials science 
involves the applications of materials to health care, especially to reconstructive surgery. In 
the past, many implantations failed due to infections or a lack of knowledge about toxicity 
of the selected materials. In this case, the use of calcium phosphates, since they are the most 
important inorganic constituents of hard tissues in vertebrates, is valid due to their chemical 
similarity to the mineral component of mammalian bones and teeth. Thus, calcium 
phosphate based biomaterials are now used in many different applications throughout the 
body, covering all areas of the skeleton. These applications include dental implants, 
percutaneous devices and use in periodontal treatment, treatment of bone defects, fracture 
treatment, total joint replacement (bone augmentation), orthopaedics, cranio-maxillofacial 
reconstruction, otolaryngology and spinal surgery (Dorozhkin 2010). 
In this chapter we will give details about the principal characteristics of bone, tooth and 
pathological calcifications where the calcium phosphates are present (section 2); the 
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chemical-physical characteristics and the methods to synthesize biomimetic hydroxyapatites  
(section 3); and the main  applications of these in the nanobiotechnology field (section 4). 
2. Biogenic hydroxyapatite 
In biological systems, calcium phosphates are the principal inorganic constituent of normal 
(bones, teeth, fish enameloid, deer antlers and some species of shells) and pathological 
(dental and urinary calculus and stones, atherosclerotic lesions) calcifications. Except for 
small portions of the inner ear, all hard tissue of the human body is made of calcium 
phosphates. Structurally, they occur mainly in the form of poorly crystallized non-
stoichiometric F, Na, Mg and carbonate substituted hydroxyapatite [Ca10(PO4)6(OH)2] (HA) 
(Dorozhkin 2010). We will thus give details in this section about the principal characteristics 
of bone, tooth and pathological calcifications, highlighting the fact that the living organisms 
can produce different amazing high-performance materials. 
2.1 Bone  
Bones are rigid organs that form part of the endoskeleton of vertebrates. Their function is to 
move, support and protect the various organs of the body, produce red and white blood 
cells and store minerals (Loveridge 1999; Reddi 1994). Bones appear in a variety of shapes 
and have a complex internal and external structure, they are lightweight, yet strong and 
hard, in addition to satisfying their many other functions. One of the types of tissues that 
constitutes bone is the mineralized osseous tissue, also called bone tissue, that gives it 
rigidity and honeycomb-like three-dimensional structure (Cowles et al., 1998). Other types 
of tissue found in bones include marrow, endosteum and periosteum, nerves, blood vessels 
and cartilage (Tzaphlidou 2008). There are 206 bones in the adult body and about 300 bones 
in the infant body. Bone tissue consists of cells embedded in a fibrous, organic matrix, the 
osteoid, which is primarily constituted by type I collagen (90%) and 10% amorphous ground 
substance (primarily glycosaminoglycans and glycoproteins). Osteoid comprises 
approximately 50% of bone by volume and 25% by weight (Urist 2002).  
Osteoblasts are mono-nucleate cells responsible for the secretion of osteoid and subsequent 
bone formation through the mineralization of the osteoid matrix. They strongly produce 
alkaline phosphatase, an enzyme that has a role in the mineralisation of bone, as well as 
many matrix proteins. When osteoblasts are trapped in the bone matrix, which they 
themselves produced, they become star-shaped cells named osteocytes, the most abundant 
cells found in bone (Wozney 1992).  
Osteocytes are mature bone cells, networked to each other via long processes that occupy 
tiny canals called canaliculi, which are used for exchange of nutrients and waste. They are 
actively involved in the maintenance of bony matrix, through various mechanosensory 
mechanisms regulating the bone's response to stress. Bone is a dynamic tissue constantly 
being reshaped by osteoblasts, cells which build bone, and osteoclasts, cells which resorb it 
(Manolagas 2000).  
Osteoclasts are multi-nucleated cells responsible for the resorption of bone through the 
removal of the bone's mineralized matrix. The removal process begins with the attachment 
of the osteoclast to the osteon (predominant structures found in compact bone); the 
osteoclast then induces an infolding of its cell membrane and secretes collagenase and other 
enzymes important in the resorption process, such as tartrate resistant acid phosphatase, 
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secreted against the mineral substrate. During childhood, bone formation exceeds resorption 
but, as the aging process occurs, resorption exceeds formation (Legeros & Craig 1993). 
The characteristic rigidity and strength of bone derives from the presence of mineral salts, 
that permeate the organic matrix, formed by the osteoid mineralization, due to the secretion 
of vesicles containing alkaline phosphatase, by the osteoblasts (Boskey 2007). The mineral 
phase comprises approximately 50% of bone by volume and 75% by weight. The principal 
constituents of bone mineral are calcium phosphate, mainly carbonated hydroxyapatite, 
amorphous calcium phosphate and calcium carbonate, with lesser quantities of sodium, 
magnesium, silicon and fluoride (Palmer et al., 2008). 
The whole architecture of bone is very complex: starting from the smallest constituting 
elements to the largest scales, the bone is not only organized in an anisotropic manner, but 
the arrangement of its constituting elements is hierarchical; this means that its structural 
units are organized at increasing size levels, and this feature confers unique properties to 
the whole bone structure. To better understand the complex bone architecture, several 
hierarchical models have been proposed. Weiner and Wagner have identified seven discrete 
levels of hierarchical organization in bone (Figure 1), which we describe here (Weiner & 
Wagner 1998). In their model, bone is considered as a family of materials with the 
mineralized collagen fibre as the primary building block for subsequent higher order 
architectures. 
 
 
Fig. 1. Seven hierarchical levels of organization of the bone family of materials as proposed 
by Weiner and Wagner. Reproduced with permission from (Weiner & Wagner 1998). 
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The structure of bone differs greatly among the different locations in the skeleton, but the 
basic nanoscale structure consisting of mineralized collagen remains the same throughout. 
The first hierarchical level consists of the molecular components: water, HA, collagen and 
other proteins. The crystals of HA are plate-shaped and are among the smallest known 
biological crystals (Table 1).  
 
Composition Enamel Dentin Bone 
Calcium [wt %][a] 36.5 35.1 34.8 
Phosphorus (as P) [wt %][a] 17.7 16.9 15.2 
Ca/P (molar ratio) [a] 1.63 1.61 1.71 
Sodium [wt %][a] 0.5 0.6 0.9 
Magnesium [wt %][a] 0.44 1.23 0.72 
Potassium [wt %][a] 0.08 0.05 0.03 
Carbonate (as CO32-) [wt 
%][b] 
3.5 5.6 7.4 
Fluoride [wt %][a] 0.01 0.06 0.03 
Chloride [wt %][a] 0.30 0.01 0.13 
Pyrophosphate (as P2O74-) 
[wt %][b] 
0.022 0.100 0.070 
Total inorganic [wt %][b] 97 70 65 
Total organic [wt %][b] 1.5 20 25 
Water [wt %][b] 1.5 10 10 
a axis [Å][c] 9.441 9.421 9.410 
c axis [Å][c] 6.880 6.887 6.890 
Crystallinity index, 
(HA=100) 
70 – 75 33 - 37 33 - 37 
Typical crystal sizes [nm] 100 × 50 × 50 μm 35 × 25 × 4
50 × 25 × 
4 
Ignition products (800 °C) β-TCP + HA β-TCP + HA 
HA + 
CaO 
Elasticity modulus (GPa) 80 15 0.34 - 13.8 
Compressive strength (MPa) 10 100 150 
Table 1. Comparative composition and structural parameters of inorganic phases of adult-
human calcified tissues ([a]Ashed samples. [b]Unashed samples. [c]Lattice parameters: ± 0.003 
Å). 
Though the size of biological apatite crystals reported in the literature varies due to the 
different treatment methods and analysis techniques utilized, it is generally around the 
nanometric level, with values in the ranges of 30–50 nm (length), 15–30 nm (width) and 2–10 
nm (thickness) (Fernandez-Moran & Engstrom 1957). In early studies, apatite needles were 
observed, but other studies suggest that platelets are the dominant morphology and that the 
apparent needles are most likely to be platelets viewed edge-on (Traub et al., 1989). 
Noncollagenous proteins (NCPs) are also present but make up 10% or less of the total 
protein content in the bone matrix. The specific functions of the NCPs are still not 
completely understood. In addition to influencing crystal nucleation and growth, NCPs also 
play roles in cell signalling and ion homeostasis (Feng et al., 2006).  
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The second level is formed by the mineralization of collagen fibrils. Tiny plate-like crystals 
of biological apatite in bone occur within the discrete spaces within the collagen fibrils and 
grow with specific crystalline orientation along the c-axes, which are roughly parallel to the 
long axes of the collagen fibrils (Termine et al., 1981). The HA growth is somehow limited 
by these small intercollagenous spaces, which are approximately 50 nm in length, 25 nm in 
width and 2–3 nm thick (Cui et al., 2007). The location of these crystals in the fibril was 
demonstrated in a study by Traub et al. that showed that mineralized collagen fibrils had 
the same banded pattern as negatively stained collagen fibrils (Traub et al., 1989). This 
indicated that mineral is concentrated in the hole zones of the fibril. It was proposed that 
these mineral platelets were arranged in parallel like a stack of cards within the interstices of 
the fibril. Olszta et al. concluded from electron diffraction studies that the mineral plates are 
not quite as ordered as previously assumed (Olszta et al., 2007). This imperfect arrangement 
of nearly parallel crystals has been supported by recent small-angle X-ray scattering (SAXS) 
and transmission electron microscopy (TEM) data from Burger et al. (Burger et al., 2008). 
The third level of hierarchy is composed of arrays of these mineralized collagen fibrils. 
These fibrils are rarely found isolated, but rather almost always associated as bundles or 
other arrangements, often aligned along their long axis. Type I collagen molecules are self-
assembled into fibrils with a periodicity of 67 nm and with 40 nm gaps between the end and 
the head  of their molecules, into which the apatite crystals are placed. A composite of these 
two constituents forms mineralized fibrils (Wahl & Czernuszka 2006; Bigi et al., 1991; Bigi et 
al., 1996; Bigi et al., 1997). The fourth level is the patterns of arrays that are formed. These 
include parallel arrays, woven arrangements, plywood like structures and radial arrays like 
those found in dentin. Cylindrical structures called osteons make up the fifth level. Osteons 
are formed with significant cellular activity and remodeling; osteoclasts resorb bone and 
form a tunnel and osteoblasts subsequently lay down lamellae in stacked layers until only a 
small channel (Haversian canal) is left behind. These channels serve as a conduit for nerves 
and blood supply to the bone cells. The sixth level of bone organization is the classification 
of osseous tissue as either spongy (trabecular or cancelous) or compact (cortical). Cancellous 
bone is extremely porous (75-95% porosity), providing space for marrow and blood vessels, 
but has much lower compressive strength. Cortical bone is the dense outer layer (5-10% 
porosity) that allows many of the support functions of bone (Fratzl et al., 2004). Therefore, 
the mechanical properties of cortical bone represent the benchmark for synthetic bone. The 
seventh level is simply the whole bone on the macroscopic scale, incorporating all of the 
lower levels of hierarchy. 
2.2 Tooth  
The mammalian body contains numerous mineralized tissues as reported in the previous 
paragraph, but the tissue with the most robust mechanical properties is enamel. Enamel is 
the hardest material formed by vertebrates and is the most highly mineralized skeletal tissue 
present in the body (Whittaker 1982). Mature enamel is composed of 95-97% carbonated HA 
by weight with less than 1% organic material. The high degree of mineralization makes 
enamel a fascinating model for understanding fundamental mineralization processes and 
processes that occur within an extracellular matrix.  
It is distinct from bone in terms of architecture, pathology and the biological mechanisms 
mediating its formation. Understanding the biological formation of different mineralized 
structures could lead to innovative approaches toward engineering novel scaffolds and 
providing new therapeutics. Additionally, unlike other biomineralized tissues, such as bone 
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and dentin, mature enamel is acellular and does not resorb or remodel. As a result, enamel 
regeneration cannot occur in vivo following failure and is therefore an attractive target for 
future biomimetic and therapeutic approaches. The mammalian tooth is made up of four 
distinct structures: enamel, dentin, pulp and cementum (Figure 2). 
 
 
Fig. 2. Hierarchical architecture of mammalian enamel. Enamel (E) is the outermost layer at 
the crown of the tooth and resides above the dentin (D). The pulp (P) contains nerves and 
blood vessels, while the cementum (C) is the outermost layer of mineralized tissue 
surrounding the root of the tooth allowing the tooth to be anchored to the jawbone through 
the periodontal ligament (PDL). The bulk image depicts the E organ, the transition across 
the D-E junction, and the D below. On the mesoscale level, prismatic E consisting of 
weaving of rods (or prisms) that range from 3 to 5 μm in diameter can be visualized. Upon 
further magnification, the micrometer scale shows the composition of a single rod. The 
nanometer scale reveals a highly organized array of individual HA crystallites 
(approximately 30 nm thick, 60 nm wide, and several millimeters in length), which are 
preferentially aligned along the c-axis. Reproduced with permission from (Tamerler & 
Sarikaya 2008). 
The pulp contains nerves, blood vessels, fibroblasts and lymphocytes, while the mineralized 
organs of the tooth include enamel, dentin and cementum (Tamerler & Sarikaya 2008). 
Enamel makes up the uppermost 1-2 mm of the tooth crown and contains a high mineral 
content, giving it a high modulus but also making it susceptible to cracking. Dentin lies 
below the enamel and is tougher, forming the bulk of the tooth and absorbing stresses from 
enamel, preventing its fracture (Arsenault & Robinson 1989). The composition of dentin is 
similar to that of bone. The cementum is the mineralized layer that surrounds the root of the 
tooth covering the dentin layer and some of the enamel layer. The cementum allows for the 
anchoring of the tooth to the alveolar bone (jawbone) through the periodontal ligament. The 
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primary function of the tooth is for mastication of food; however, some species use them for 
attacking prey and for defence. It also faces the lifelong challenge of maintaining robust 
mechanical properties in a bacteria-filled environment. 
The enamel and dentin tissues give rise to a tough, crack-tolerant and abrasion-resistant 
tissue through their unique architectures and mineral compositions. Enamel is highly 
patterned and consists of organized interweaving bundles of crystallites (called rods or 
prisms). It has a higher reported toughness than that of crystalline HA, indicating that the 
organization of the crystallites is essential for enamel function (White et al., 2001). Because of 
the high mineral content and minimal organic, enamel is brittle. Interestingly, the 
architecture of the enamel crystallites can deflect a propagating crack preventing it from 
reaching the dentin-enamel junction (DEJ), which also has been shown to resist 
delamination of the tissues despite their differences in composition (Imbeni et al., 2005). The 
mechanical properties of enamel, dentin and the DEJ are not completely understood and are 
a significant area of research. Understanding the properties of these tissues could serve to 
motivate further engineering of more robust dental materials as well as to inspire fabrication 
of nonbiological materials. 
Similar to bone, enamel possesses a complex architecture, which can be broken into several 
hierarchical levels from the nanoscale to the macroscale (Paine et al., 2001). On the 
nanoscale, the protein-protein and protein-mineral interactions in the presence of 
supersaturated ions create a highly organized array of HA crystallites that grow 
preferentially along the c-axis (Wen et al., 2000). The sizes of these crystallites depend on the 
stage of the mineralization. The crystallites grow primarily in length during the secretory 
stage and continue to grow in width and thickness during the maturation stage. The 
assembly of amelogenin has been shown to be crucial for the proper development of enamel 
crystallites. Disruption of the assembly alters formation on the nanoscale, subsequently 
affecting larger length scales and giving rise to a diseased or malformed enamel phenotype. 
On the mesoscale level, there are three main structural components: the rod, the interrod 
and the aprismatic enamel. The main component of enamel on the mesoscale includes rods, 
which are bundles of aligned crystallites that are “woven” into intricate architectures that 
are approximately 3-5 μm in diameter (Cui & Ge 2007). 
The second structural component of the enamel matrix is the interrod (or interprismatic) 
enamel, which surrounds and packs between the rods. The difference between the rod and 
the interrod is the orientation of HA crystals; the rod contains aligned crystallites, whereas 
the mineral in the interrod is less ordered. These structures coalesce to form the tough tissue 
of enamel, which can withstand high forces and resist damage by crack deflection.  
The third structure, aprismatic enamel, refers to the structures containing HA crystals that 
show no mesoscale or macroscale alignment. The macroscale architecture includes specific 
zones of enamel that have unique characteristics, which contribute to the whole tissue. The 
enamel adjacent to the DEJ exhibits a gradual transition from dentin to enamel. Aprismatic 
regions of enamel have been proposed to be primitive areas of the tooth serving as a 
toughening mechanism due to their flexible nature (Wang & Weiner 1998). Several authors 
have identified these aprismatic areas to be located adjacent to the DEJ and at the incisal 
surface of both deciduous and permanent human enamel (Kodaka et al., 1989). The Tomes’ 
process, a unique structure present at the secretory pole of an enamel-forming cell, is 
responsible for aligned mineral formation in the prismatic enamel. The absence of this 
process may give rise to the aprismatic zone in the tooth. 
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2.3 Pathological calcifications 
In the body of mammals, osteoblasts and odontoblasts fix ions of calcium and 
orthophosphate and then precipitate biological apatite onto an organic matrix. This is the 
process of physiological biomineralization that is restricted to the specific sites in skeletal 
tissues, including growth plate cartilage, bones and teeth. Unfortunately, owing to ageing, 
to various diseases and under certain pathological conditions, blood vessels and some 
internal organs are calcified as well (Daculsi et al., 1997). This process is called pathological 
calcification or ectopic mineralization and leads to a morbidity and a mortality. In general, 
any type of abnormal accumulation of calcium phosphates in wrong places is accounted for 
by a disruption of systemic defense mechanism against calcification (Kazama et al., 2006). 
Unwanted depositions always lead to various diseases, for instance: soft tissue calcification 
(in damaged joints, blood vessels, dysfunctional areas in the brain, diseased organs, 
scleroderma, prostate stones) (Brancaccio & Cozzolino 2005), kidney and urinary stones 
(Achilles et al., 1995), dental pulp stones and dental calculus (Hayashizaki et al., 2008), 
salivary stones, gall stones, pineal gland calcification, atherosclerotic arteries and veins 
(Marra et al., 2006), coronary calcification, cardiac skeleton, damaged cardiac valves, 
calcification on artificial heart valves (Weissen-Plenz et al., 2008; Bigi et al., 1988), carpal 
tunnel, cataracts, malacoplakia, calcified menisci, dermatomyositis and other. All these cases 
are examples of a calcinosis, which might be described as a formation of calcium phosphate 
deposits in any soft tissue (Laird et al., 2006). 
Contrary to the mineral phases of the normal calcifications (bone, dentin, enamel, 
cementum, antlers), which consist of only one type of calcium phosphate (namely, biological 
apatite), the mineral phases of abnormal and/or pathological calcifications are found to 
occur as single or mixed phases of other types of calcium phosphates and/or other 
phosphatic and non-phosphatic compounds, in addition to or in place of biological apatite 
(Wesson & Ward 2007). This happens because the solution pH is often relatively low in the 
places of pathological calcifications. However, in some cases, the chemical composition of an 
unwanted inorganic phase might depend on the age of the pathological calcification and its 
location (Legeros et al., 1988). It is interesting to note that the mineral phases of animal 
calculus (e.g., from dog) was found to consist of calcium carbonate and biological apatite, 
while human calculi do not contain calcium carbonate. Some findings suggested that the 
mechanisms and factors regulating the physiological biomineralization might be similar to 
those influencing the ectopic mineralization: both were initiated by various organics (i.e., 
membrane-enclosed particles released from the plasma membrane of mineralization-
competent cells), that were present (Kirsch 2006). 
3. Synthetic biomimetic hydroxyapatites 
Biomimetism of synthetic calcium phosphates can be carried out at different levels, such as 
composition, structure, morphology, bulk and surface chemical–physical properties. 
Biomaterials can be turned into biomimetic imprinting all these characteristics in order not 
only to optimise their interaction with biological tissues, but also to mimic biogenic 
materials in their functionalities. Detailed information on calcium phosphates, their 
synthesis, structure, chemistry, other properties and biomedical application have been 
comprehensively reviewed recently (Dorozhkin 2010; LeGeros 2008).  
In this section the chemical-physical characteristics and some methods to synthesize 
biomimetic calcium phosphates will be described. 
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3.1 Chemical-physical characteristics of nanocrystalline hydroxyapatites 
The study of nanocrystalline calcium phosphate physical-chemical characteristics and, 
thereafter, the possibility to imitate bone mineral for the development of new advanced 
biomaterials is constantly growing. The possibility to synthesize in the laboratory synthetic 
biomimetic compounds makes it possible to consider these systems as a bone mineral 
“model”, enabling to investigate on the one hand the interaction between bone-like apatite 
nanocrystals and the components of surrounding fluids (ions, proteins…) and, on the other 
hand, to follow surface interactions with drugs aimed at being delivered in vivo. 
Among the peculiarities of these compounds, their plate-like morphology (elongated 
towards the c-axis) is one obvious specificity as compared to regular HA. Another difference 
is of course the mean crystallite size, of the order of 15-30 nm in length and ca. 6-9 nm in 
width. From a chemical point of view, the composition of nanocrystalline apatites also 
strongly differs from that of HA. Although it has been the object of much controversy 
during several decades in the middle of the 20th Century, the global chemical composition 
of biological apatites (or their synthetic analogues) can generally be described as: 
Ca10-x  (PO4)6-x (HPO4 or CO3)x (OH or ½ CO3)2-x with 0 ≤ x ≤ 2 
(except maybe for very immature nanocrystals which may depart from this generic 
formula). In particular, this expression underlines the presence of vacancies in both Ca and 
OH sites. For example, Legeros et al. (Legros et al., 1987) analyzed various cortical bone 
specimens, suggesting the following relatively homogeneous composition, unveiling high 
vacancy contents:  
Ca8.3 (PO4)4.3 (HPO4 or CO3)1.7 (OH or ½ CO3)0.3 
Minor substitutions are also found in biological apatites involving for example monovalent 
cations (especially Na+) in cationic sites. In this case, charge compensation mechanisms have 
to be taken into account.  
It should however be kept in mind that such chemical formulas only enable to have a 
“global” insight on the nature and amount of ions present in the compound, but it does not 
reflect possible local variations that may be observed on the nanocrystals or in vivo within 
the osteons (Paschalis et al., 1996), linked to the local apatite crystal formation and, in vivo, 
to continuous bone remodelling.  
The characterization of nanocrystalline apatites is a relatively arduous task due to their poor 
crystallinity and metastability. But despite the complexity of these systems, recent in-depth 
investigations have succeeded to reveal their particular surface features (and related 
reactivity in wet media) that may be exploited for the setup of new biomaterials, or for a 
better understanding of natural or pathological biomineralization phenomena. Recent 
advances in the characterization of apatite nanocrystals were obtained thanks to the use of 
spectroscopic techniques and, in particular, Fourier Transform Infrared (FT-IR) 
spectroscopy. FT-IR method is useful for drawing conclusions on the local chemical 
environment of phosphate, carbonate and hydroxide ions as well as water molecules in such 
systems. Detailed analyses of the phosphate groups by FT-IR have enabled to distinguish in 
nanocrystalline apatites the presence of additional bands that cannot be attributed to 
phosphate groups in a regular apatitic environment (Rey et al., 1990; Rey et al., 1989). These 
chemical environments have been referred to by Rey as “non-apatitic” environments.  
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Taking into account all the above data, nanocrystalline apatites (whether biological or their 
synthetic analogues prepared under close-to-physiological conditions) may thus most 
probably be described as the association of an apatitic core (often non stoichiometric) and a 
structured by fragile surface hydrated layer containing water molecules and rather labile 
ions (e.g. Ca2+, HPO42-, CO32-…) (Drouet et al., 2009) occupying non-apatitic crystallographic 
sites (although in the case of biomimetic apatites the layer is directly exposed on the surface 
and not included in a “sandwich-like” structure between two “apatitic” layers). A schematic 
model for such nanocrystalline apatites is given in Figure 3 (Eichert et al., 2007).  
 
 
Fig. 3. Schematic modelling of a biomimetic apatite nanocrystal (a) and interaction with 
surrounding fluids (b) (from reference (Eichert et al., 2007)), with permission. 
The presence of this hydrated surface layer (Sakhno et al., 2010) is thought to be responsible 
for most of the properties of biomimetic apatites and, in particular, their high surface 
reactivity in relation with surrounding fluids (which is probably directly linked to a high 
mobility of ionic species contained within this layer) may explain, from a physical-chemical 
viewpoint, the role of bone mineral in homeostasis in vivo. This layer indeed contains labile 
ions that can potentially be exchanged by other ions from the surrounding solution, or by 
small molecules, which may be exploited for couplings with proteins or drugs. It is 
interesting to remark that the typical non-apatitic features mentioned above tend to 
progressively disappear during the ageing of the nanocrystals in solution (Cazalbou et al., 
2005; Drouet et al., 2009). This process is referred to as “maturation” and has been related to 
the progressive growth of apatite domains at the expense of the surface hydrated layer 
(Cazalbou et al., 2004). 
This maturation process is thought to be linked to the metastability of such poorly-
crystallized non stoichiometric apatites, which steadily evolve in solution towards 
stoichiometry and better crystallinity (Cazalbou et al., 2005; Cazalbou et al., 2004). This 
evolution can be for example witnessed by the decrease of the amount of non-apatitic 
HPO42- ions upon ageing, or else by the decreased potentialities to undergo ion exchanges 
(Cazalbou et al., 2005). One illustration of such effects can be given for example by the 
decreased exchangeability of HPO42- by CO32- observed on carbonated apatites matured for 
incremented amounts of time. Additionally, beside this compositional evolution, some 
structural and microstructural features also tend to evolve such as the mean crystallite size 
which increases upon maturation. The control of synthesis parameters such as pH, 
temperature or maturation time can thus enable one to tailor the physical-chemical 
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properties of biomimetic apatites (Drouet et al., 2009) and, in particular, their surface 
reactivity, so to mimic for example mature bone mineral or else newly-formed bone apatite. 
3.2 Preparation of biomimetic hydroxyapatites 
Many different methodologies have been proposed to prepare nanosized and/or 
nanocrystalline HAs (Schmidt 2000; Cushing et al., 2004; Wang et al., 2005; Mao et al., 2007). 
These are: wet chemical precipitation (Wang & Shaw 2007; Huang et al., 2004; Liou et al., 
2004; Ganesan & Epple 2008; Zhang & Lu 2007), sol–gel synthesis (Sun et al., 2007; Chai & 
Ben-Nissan 1999; Ben-Nissan & Choi 2006; Choi & Ben-Nissan 2007), co-precipitation 
(Lopez-Macipe et al., 1998; Tas 2000), hydrothermal synthesis (Guo et al., 2007; Chaudhry et 
al., 2006), mechanochemical synthesis (Yeon et al., 2001), microwave processing (Siva Rama 
Krishna et al., 2007; Liu et al., 2005; Rameshbabu et al., 2005), vapour diffusion (Iafisco et al., 
2010a), silica gel template (Iafisco et al., 2009a), emulsion-based syntheses (Phillips et al., 
2003) and several other methods by which nanocrystals of various shapes and sizes can be 
obtained (Layrolle & Lebugle 1994; Ye et al., 2008). In general, the shape, size and specific 
surface area of the apatite nanocrystals appear to be very sensitive to both the reaction 
temperature and both the reactant addition rate. HAs with different stoichiometry and 
morphology have been prepared and the effects of varying powder synthesis conditions on 
stoichiometry, crystallinity and morphology, have been analysed. The effects of varying the 
concentration of the reagents, the reaction temperature, initial pH, ageing time and the 
atmosphere within the reaction vessel have also been studied (Koutsopoulos 2002). In order 
to optimise its specific biomedical applications, especially drug delivery function, the 
physical–chemical features that should be tailored in synthetic biomimetic HA are 
dimensions, porosity, morphology and surface properties (Roveri et al., 2008c; Tampieri et 
al., 2009). Biomimetic carbonate–hydroxyapatite nanocrystals have been synthesized by 
using the sitting drop vapour diffusion technique, for the first time by Iafisco et al. (Iafisco et 
al., 2010a). The method consists of diffusing vapours of an aqueous solution of NH4HCO3 
through drops containing an aqueous mixture of (CH3COO)2Ca and (NH4)2HPO4 in order to 
increase slowly their pH. This synthesis has been performed in a crystallization mushroom, 
a glass device developed for protein and small molecules crystallization (Figure 4). The 
concentrations of the reagents, the final pH and the crystallization time have been optimized 
to produce pure carbonate–HA as a single phase. X-Ray diffraction, Fourier transformed 
infrared spectroscopy and transmission electron microscopy have been utilized to 
characterize the synthesized carbonated substituted HA crystals, which display nanometric 
dimensions, platelike morphology and low crystallinity degree, closely resembling the 
inorganic phase of bones, teeth and many pathological calcifications. 
Porous HA biomimetic ceramics in simulating spongy bone morphology (porosity varying 
from a microporosity > 1 μm to a macroporosity ranging from 300 to 2000 μm) has been 
prepared using various technologies to control pore dimension, shape, distribution and 
interconnections. Pore sizes and pore morphology are directly related to bone formation, 
since they provide surface and space for cell adhesion and bone ingrowth. On the other 
hand, pore interconnection provides the way for cell distribution and migration, as well as it 
allows an efficient in vivo blood vessel formation suitable for sustaining bone tissue neo-
formation and possibly remodelling. Namely, porous HA ceramics can be colonized by bone 
tissues (Mastrogiacomo et al., 2006; Karageorgiou & Kaplan 2005). Therefore, 
interconnecting macroporosity (pore size > 100 mm), which is defined by its capacity to be 
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Fig. 4. Crystallization mushroom sketch. Carbonate-hydroxyapatite crystals were grown in 
sitting droplets on microbridges. NH3(g) and CO2(g) slowly diffused from the reservoir to 
the droplet through the small opening in the plate at bottom. 
colonized by cells, is intentionally introduced in solid ceramics (Lu et al., 1999). Porous HA 
ceramics processed by high-temperature treatment present a significant reduction of 
bioreactivity and growth kinetics of new bone due to the lack of resorbability (Rodriguez-
Lorenzo et al., 2001). However, the low resorbability of sintered HA-ceramics appears useful 
when they have to be implanted with a defined 3D form. Macroporosity is usually formed 
due to release of various volatile materials and, for that reason, incorporation of pore 
creating additives (porogens) is the most popular technique to create macroporosity. Among 
porogens additives we can mention paraffin, naphthalene, fluor, hydrogen peroxide, 
polyvinyl butyral, etc (Tancret et al., 2006; Walsh & Tanaka 2001; Chevalier et al., 2008). 
These additives are admixed to HA powders or slurries. After moulding, the organics burn 
away from the moulding body during sintering. This approach allows direct control of the 
pore characteristics, which are a function of the amount and properties of the volatile phase. 
Several other techniques, such as replication of polymer foams by impregnation, dual-phase 
mixing technique, freeze casting, strereolithography and foaming of gel-casting suspensions 
and transformation of porous calcium carbonate from biological origin (marine corals or 
echinoderms skeletons) into porous calcium phosphates by treatment  with phosphate 
solutions under hydrothermal conditions have been applied to fabricate porous calcium 
phosphate ceramics (Gonzalez-McQuire et al., 2005; Liu 1997; Walsh et al., 2005; Charriere et 
al., 2003). By using the latter technique the interconnected porosity of the aragonitic or 
calcitic skeletons of corals or echinoderms is maintained after transformation to HA or 
mixtures of HA and other calcium phosphates (Araiza et al., 1999). The preparation methods 
of porous bioceramics has been recently reviewed by Sopiana et al. (Sopyan et al., 2007). 
Many studies have demonstrated that HA ceramics can be used to deliver steroids, 
antibiotics, proteins, hormones, anticancer drugs. Porous ceramics closely mimicking 
spongy bone morphology have been synthesized by impregnation of cellulosic sponges with 
poorly crystalline HA water suspension (Figure 5) (Palazzo et al., 2005). These porous 
ceramics have been tested as controlled drug delivery bone grafts to evaluate the 
fundamental parameters that control release kinetics. A theoretical approach, based on the 
use of the Finite Element Method, was adopted to describe the ibuprofen-lysine and 
hydrocortisone Na-succinate release kinetics, comparing the numerical results with the 
experimental ones.  
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Fig. 5. Scanning electron microscopy image of porous hydroxyapatite 
4. Applications of biomimetic hydroxyapatites 
The main driving force behind the use of calcium phosphates as bone substitute materials is 
their chemical similarity to the mineral component of mammalian bones and teeth, as 
previously explained. As a result, in addition to being non-toxic, they are biocompatible, not 
recognized as foreign materials in the body and, most importantly, they exhibit bioactive 
behavior and integrate into living tissue by the same processes active in remodeling healthy 
bone. This leads to an intimate physical-chemical bond between the implants and bone, 
termed osteointegration (Puleo 2004). In fact, materials can interact with biomolecules as 
well as with living systems and these interactions can be used to develop new materials and 
technologies. In particular, surface interaction of proteins and peptides with calcium 
phosphates based biomaterial represents the first and pivotal event when materials are 
implanted within an organism and must integrate in the host tissues, affecting the 
accompanying biological responses, namely cell attachment and activation (Iafisco et al., 
2008; Iafisco et al., 2010b; Palazzo et al., 2009). More to the point, calcium phosphates are 
also known to support osteoblast adhesion and proliferation (Hong et al., 2003; Sader et al., 
2009). Even so, the major limitations to use calcium phosphates as load-bearing biomaterials 
are their mechanical properties; namely, they are brittle with a poor fatigue resistance 
(Dorozhkin 2009). The poor mechanical behavior is even more evident for highly porous 
ceramics and scaffolds because porosity greater than 100 µm is considered a requirement for 
proper vascularization and bone cell colonization (Sader et al., 2009). That is why, in 
biomedical applications, calcium phosphates are used primarily as fillers and coatings (de 
Groot 1993). 
4.1 Scaffolds 
Following the biomimetic approach, inspiring to Nature, natural wood templates have been 
selected as a starting point to obtain open-pore geometries with high surface area and 
microstructure allowing cell in-growth and reorganization and providing the necessary 
space for vascularisation (Li et al., 2006; Zimmerman et al., 2002). In fact, the alternation of 
fibre bundles and channel-like porous areas makes the wood an elective material to be used 
as template in starting the development of new bone substitute biomaterials by an ideal 
biomimetic hierarchic structure (Singh et al., 2003). Hydroxyapatite bone scaffolds 
characterized by highly organized hierarchical structures have been recently obtained by 
chemically transforming native woods through a sequence of thermal and hydrothermal 
processes. The whole chemical conversion has been carried out through five chemical  steps 
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from native wood to porous hydroxyapatite: i) pyrolysis of ligneous raw materials to 
produce carbon templates characterized by the natural complex anisotropic pore structure; 
ii) carburization process by vapour or liquid calcium permeation to yield calcium carbide; 
iii) oxidation process to transform calcium carbide into calcium oxide; iv) carbonation by 
hydrothermal process under CO2 pressure for the further conversion into calcium carbonate; 
v) phosphatization process through hydrothermal treatment to achieve the final 
hydroxyapatite phase. 
The five steps of the phase transformation process have been set up in order to achieve total 
phase conversion and purity  maintaining the original native microstructure. An innovative 
biomimetic apatite hierarchically structured in parallel fastened hollow microtubules has 
been synthesized, structurally characterized and proposed as new inorganic biomorphic 
scaffold providing a biomimetic nanostructured surface for fascinating bone engineering 
applications (Tampieri et al., 2009). The SEM image reported in Figure 6A demonstrates that 
the structured anisotropy typical of the native woods was preserved on the macro-scale, 
exhibiting in the case of rattan pore sizes in the range 100–300 μm, revealing an ordered 
fastening of parallel micro-tubes 100–150 μm long and 15–30 μm wide with a hollow core of 
about 10–25 μm in diameter, organized like the cell morphology of the natural wood used as 
the starting template for its synthesis. SEM image reported in Figure 6B of the newly formed 
HA surface morphology shows typical needle-like nuclei grown on the surface, proving the 
concomitant occurrence of a dissolution/precipitation process at sub-micron level, in 
agreement with hypotheses previously reported. This surface nanostructured morphology 
of the unidirectional fastened hollow HA microtubules allows biological systems like cells to 
utilize biomorphic scaffolds on the micrometer level which are also biomimetic for 
composition and structure on the nanometer scale. 
 
 
Fig. 6. Detailed SEM images of pine wood-derived hydroxyapatite: a) microstructure of 
wood-derived parallel fastened hydroxyapatite microtubes; b) typical needle-like HA nuclei 
grown on the micro-tube surface; inset in b shows an higher magnification of picture b. 
Reproduced with permission from (Tampieri et al., 2009).  
4.2 Drug delivery 
Over the past few decades, the rise of modern pharmaceutical technology and the amazing 
growth of the biotechnology industry have revolutionized the approach to drug delivery 
systems development. For most of the industry’s existence, pharmaceuticals have primarily 
consisted of relatively simple, fast-acting chemical compounds that are dispensed orally (as 
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solid pills and liquids) or injected. During the past three decades, however, complex 
formulations that control the rate and period of drug delivery (i.e., time-release medications) 
and that target specific areas of the body for treatment have become increasingly common. 
A controlled release drug delivery system should be able to achieve the following benefits: 
(i) maintenance of optimum therapeutic drug concentration in the blood with minimum 
fluctuation; (ii) predictable and reproducible release rates for extended duration; (iii) 
enhancement of activity duration for short half-life drugs; (iv) elimination of side effects, 
frequent dosing and wastage of drug; and (v) optimized therapy and improved patient 
compliance. 
Hydroxyapatites and other calcium phosphates may find several applications in implant 
drug devices. In fact, as drug carriers, calcium phosphate nanoparticles have some 
advantageous properties. They are dissolved at low pH (around 4), e.g. in lysosomes after 
the cellular intake or in the environment of solid tumours, thereby releasing incorporated 
drugs or biomolecules (Roveri et al., 2008b; Epple et al., 2010). Their size can easily be 
controlled by stabilizing agents, such as polymers or nucleic acids. The nanoparticles can be 
made to fluoresce by the incorporation of lanthanide ions and they can also act as carriers 
for different drugs (Al-Kattan et al., 2010). For example, one of the most efficient ways to 
improve the bone forming ability of biomaterials is their association with bone 
morphogenetic proteins (Autefage et al., 2009). Thus the choice of the process used to 
prepare implantable bone biomaterials has an influence on the release of the associated 
bioactive molecules. Various techniques associating drugs with a calcium phosphate 
biomaterial have been reported: adsorption and impregnation allow the therapeutic agent to 
be incorporated at the surface of the biomaterial, whereas centrifugation and vacuum based-
techniques enable it to enter into pores of biomaterials (Gautier et al., 2001; Gautier et al., 
2000). 
Generally bioactive molecules, such as growth factors, are incorporated in biomaterials by 
simple impregnation, followed by drying, and the type of bonding with the substrate and 
the release rate are often undetermined (Alam et al., 2001). It is suspected that such 
associations do not allow the chemical bonding of the growth factor to the biomaterial and 
thus the release rate is often difficult to control. For example, precipitation and clustering of 
the growth factor molecules may occur and the release is only determined by local 
dissolution and diffusion rules. The uncontrolled release of growth factors has, in some 
instances, been related to an accelerated resorption of bone tissue and of the implant 
(Autefage et al., 2009). Since growth factors agents can stimulate the degradation as well as 
the formation of bone (depending on their local concentrations), they could impair the 
osteoconductivity of the coated-implant surface (Liu et al., 2007).  
Similarly, bisphosphonates molecules (BPs), by affecting bone remodeling, could also block 
the bone repair process: the drug at too high concentration could have detrimental effects on 
the fixation of the implant over longer periods of time. Zoledronate grafted to HA coating 
on titanium implants shows a dose-dependent effect on the inhibition of resorption activity 
according to the amount of zoledronate loaded (Peter et al., 2005). Local and slow 
administration of antineoplasic drug as methotraxate (MTX) is also useful to avoid systemic 
side effects and, because its time effect (the sensitivity of cells to this drug increases with 
time) is greater than dose effect (Lebugle et al., 2002). 
Adsorption, on the contrary, leads to stable association and control of the amount of 
bioactive molecules contained in the solid implant and thus of the dose released. Generally, 
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the release is rather low because most of the bioactive molecules adsorbed are irreversibly 
bound and they are not spontaneously released in a cell culture media (Errassif et al., 2010). 
They can only be displaced by mineral ions and/or soluble proteins with a stronger affinity 
for apatite surfaces but in a predicable manner, or by cell activity (Errassif et al., 2010). This 
characteristic has been observed for various growth factors like bone morphogenetic protein 
(BMP-2) or vascular endothelial growth factor (VEGF) (Midy et al., 2001; Boix et al., 2005), 
antiosteoporisis agents (Yoshinari et al., 2001; McLeod et al., 2006) and anticancer drugs as 
methotraxate and cisplatin (Barroug et al., 2004; Lebugle et al., 2002). It has been reported 
that slow release of MTX from calcium phosphate is not only due to the porosity like in most 
of the cases, but mainly due to the adsorption of MTX (Lebugle et al., 2002). A local release 
system of antibiotics could be used to prevent post-surgical infections favoring early 
osteointegration of prosthesis. Since some of the antibiotics containing carboxylic groups in 
their chemical structure, like cephalothin, were better adsorbed than others into calcium 
phosphate biomaterials, these molecules are slowly released from the carrier (Stigter et al., 
2004). Moreover, the high binding capability of apatitic support for a wide range of 
therapeutic agents allows its surface functionalisation with linking agents, such as BPs 
molecules, to anchor biologically active molecules which can be released, breaking the 
linkage as a consequence of external stimuli or internal chemical factors, such as pH and 
ionic force variation due to physiological or pathological biological process. For example, 
some works have investigated the adsorption and “smart release” of antitumoral platinum 
complexes containing BPs onto apatitic nanocrystals as bone specific drug delivery devices 
to be used for the treatment of bone tumors upon local implantation (Iafisco et al., 2009b). 
The adsorption and release of bioactive molecules are strongly affected not only by the 
chemical properties of the drug molecule, but also by the chemical and structural 
characteristics of the HA substrates. The adsorption and release of cisplatin, alendronate and 
di(ethylendiamineplatinum)medronate have been investigated using two biomimetic 
synthetic HA nanocrystal materials with either plate-shaped or needle-shaped morphologies 
and with different physical-chemical surface properties by Palazzo et al. (Palazzo et al., 
2007). These bioactive molecules were chosen in order to compare the behaviour of metal 
based drugs to that of a classical organic drug (alendronate), evaluating the effect of the 
drug molecule overall charge in influencing the drug affinity for apatite nanocrystals with 
variable structural and chemical different properties. The HA surface area and surface 
charge (Ca/P ratio), as well as the charge on the adsorbed molecules and their mode of 
interaction with the HA surface, influence the adsorption and release kinetics of the three 
drugs investigated. The results demonstrated that HA nanocrystals and anti-tumour drugs 
can be selected in such a way that the bioactivity of the drug-HA conjugate could be tailored 
for specific therapeutic applications. 
The adsorption of two different platinum complexes with cytotoxic activity, 
{ethylenediamineplatinum(II)-2-amino-1-hydroxyethane-1,1-diyl-bisphosphonate (A) and 
bis-{ethylenediamineplatinum(II)}medronate (B), on the synthesized biomimetic 
nanocrystals has been investigated by Iafisco et al. (Iafisco et al., 2009b). Both complexes 
contain a geminal bisphosphonate but, in addition, complex A contains a charged 
ammonium group (Figure 7). 
This structural difference dramatically affects the affinity of A and B towards HA 
nanocrystals, complex A having a greater affinity for calcium phosphate nanocrystals. The 
release profiles of the platinum complexes from the HA nanoparticles follow an inverted 
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Fig. 7. Sketches of {ethylenediamineplatinum(II)}-2-amino-1-hydroxyethane-1,1-diyl-
bisphosphonate (A) and bis-{ethylenediamineplatinum(II)}medronate (B). 
trend (complex B > complex A) when compared with the adsorption process. Most probably 
the less effective desorption in the case of complex A could be due to the aminic group 
present on the bisphosphonate which remains anchored to the HA matrix, coordinating and 
holding some of the ethylenediamineplatinum (Pt(en)) residues. Unmodified and HA-
adsorbed Pt complexes were tested for their cytotoxicity towards human cervix carcinoma 
cells (HeLa). The HA-loaded Pt complexes were more cytotoxic than the unmodified 
compounds A and B and their cytotoxicity was comparable to that of 
dichloridoethylenediamineplatinum [PtCl2(en)] thus indicating a common active species. 
The above results demonstrate that HA nanocrystals and antitumor drugs can be conjugated 
in such a way to yield a smart bone filler delivery system, acting both as bone substitutes 
and as platinum drug releasing agents with the final goal of locally inhibiting the tumour re-
growth and reducing the systemic toxicity. The one here described not only can ensure a 
prolonged release of active species but also improve the performance of the unmodified 
drug. Moreover, these results suggest the possibility of using the chemical-physical 
differences of HA nanocrystals, above all degree of crystallinity, crystal size and surface 
area, in order to strongly tailor the Pt complex release kinetics. Considering the biomimetic 
apatite nanocrystals functionalization effects, an attracting goal could be to obtain a drug 
delivery process characterized by a stimuli responsive kinetic. This aim induces to surface 
functionalize HA nanocrystals with different linking agents, such as bisphosphonates, to 
anchor biologically active molecules which can be released breaking the linkage as a 
consequence of external stimuli or internal chemical factors, such as pH and ionic force 
variation due to physiological or pathological biological process. 
4.3 Preventive dentistry 
The purpose of modern dentistry is the early prevention of tooth decay rather than invasive 
restorative therapy. However, despite tremendous efforts in promoting oral hygiene and 
fluoridation, the prevention and biomimetic treatment of early caries lesions are still 
challenges for dental research and public health, particularly for individuals with a high risk 
for developing caries, which is the most widespread oral disease. Recent studies indicate 
that nanotechnology might provide novel strategies in preventive dentistry, specifically in 
the control and management of bacterial biofilms or remineralization of submicrometre-
sized tooth decay. Examples include liquids and pastes that contain nano-hydroxyapatites 
for biofilm management at the tooth surface, and products that contain nanomaterials for 
the remineralization of early submicrometre-sized enamel lesions (Hannig & Hannig 2010). 
www.intechopen.com
 Advances in Biomimetics 
 
92 
Initial carious lesions in the enamel caused by adherent biofilms yield a typical 
micromorphology with a pseudo-intact surface layer on top of the subsurface body of the 
lesion as a result of reprecipitating minerals. In contrast to caries lesions caused by acids 
from bacterial metabolism, enamel erosions are induced by frequent consumption of acidic 
foods and beverages, or by gastric juice (Figure 8). This direct and continuous surface 
demineralization is only slightly diminished by the pellicle present in eroded lacunae 
(Hannig et al., 2009). 
 
 
Fig. 8. Dental erosion caused by acidic beverages or food in the oral cavity. Low pH, (pH 1–
4), destroys the enamel surface by partial and complete dissolution of the enamel 
crystallites, resulting in the release of Ca2+ and HPO42– ions. This loosens the microstructure 
of the enamel and hydroxyapatite crystallites (pale blue) become demineralized, or are lost. 
Reproduced with permission from (Hannig & Hannig 2010).  
A biomimetic approach for remineralization of initial submicrometre enamel erosions are 
based on nano-sized hydroxyapatite particles (Roveri et al., 2008a; Li et al., 2008). In vitro 
data indicate that repair at the enamel surface can be greatly improved if the dimensions of 
the apatite particles are adapted to the scale of the submicrometre- and nanosized defects 
caused by erosive demineralization of the natural apatite crystallites. HA with a size of 20 
nm fits well with the dimensions of the nanodefects caused at the enamel surface during 
acidic erosion. These particles adsorb strongly to the etched enamel surface under in vitro 
conditions and, interestingly, retard further erosive demineralization (Li et al., 2008). 
Therefore, the use of well-sized nano-apatite particles could simultaneously repair and 
prevent initial enamel-erosive lesions.  
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In another approach, biomimetic carbonate HA nanoparticles that mimic the size of natural 
dentinal HA (20 nm) or enamel apatite (100 nm) were used to repair micrometre-sized 
tooth-surface defects in vitro (Roveri et al., 2008a; Roveri et al., 2009). Clusters of these 
nanocrystals have been incorporated into toothpastes or mouth-rinsing solutions to promote 
the repair of demineralised enamel or dentin surfaces by depositing apatite nanoparticles in 
the defects. Commercially available dental prophylactic products containing carbonate HA 
nanoparticles to fill microdefects at the etched enamel surface (for example, BioRepair from 
Coswell Laboratories, Italy and from Dr. Wolff, Germany) have been proved to be effective 
in vitro after a ten-minute application onto enamel or dentin surfaces (Roveri et al., 2009). 
Recently an in vivo study has been documented that a toothpaste containing zinc–carbonate 
HA nanocrystals significantly reduced dentinal hypersensitivity after 4 and 8 weeks, 
supporting its utility in clinical practice (Orsini et al., 2010). 
Nano-hydroxyapatite toothpaste with either spheroidal or needle-like particles as an active 
component was shown to enhance the remineralization of etched enamel better than sodium 
fluoride solutions. However, the 5–10 day in vitro study had neglected the conditions of the 
oral cavity. In another in vitro study, nano-sized amorphous calcium carbonate particles that 
were applied twice a day for a period of 20 days promoted remineralization of artificial 
white-spot enamel lesions (Nakashima et al., 2009). Reconstitution and remineralization of 
dentin using nano-sized bioactive glass particles and beta-tricalcium phosphate was also 
tested in vitro, however, the mechanical properties of original dentin could not be 
reproduced (Shibata et al., 2008; Vollenweider et al., 2007). Owing to the complex organic 
and inorganic structure of the dentin, remineralizing dentin into a functional state remains 
one of the most difficult challenges in dental research (Bertassoni et al., 2009).  
5. Conclusion 
The biomimetism of biomaterials based hydroxyapatite could be carried out at different 
levels: composition, structure, morphology and surface reactivity. The aim of a researcher is 
to realise a biomaterial that is biomimetic in all these characteristics, in order not only to 
optimise the interaction of synthetic materials with biological materials but also, and more 
ambitiously, to mimic the biogenic materials in its functionality. This concept should be 
utilised in designing and preparing synthetic inorganic biomaterials in replacing hard and 
soft tissues. Nanotechnology has great potential in the biomimetism field to do just that: 
increase in efficacy by orders of magnitude. In fact, the nano-size of biological tissues 
building blocks is one of the bases of their self-organisational ability and one that needs to 
be replaced by synthetic materials in the synthesis of structured architectures with 
controlled organisation on a multiple-length scale. 
6. Acknowledgements  
We thank the University of Bologna, (funds for selected research topics) and the Inter 
University Consortium for Research on Chemistry of Metals in Biological Systems 
(C.I.R.C.M.S.B). This chapter book is in honour of Professor Alberto Ripamonti in the 
occurrence of the 80th birthday. 
Declaration of interest 
The authors state no conflict of interest and have received no payment in the preparation of 
this manuscript. 
www.intechopen.com
 Advances in Biomimetics 
 
94 
7. References 
Achilles, W.; Jockel, U.; Schaper, A.; Burk, M. & Riedmiller, H. (1995). In-Vitro Formation of 
Urinary Stones - Generation of Spherulites of Calcium-Phosphate in Gel and 
Overgrowth with Calcium-Oxalate Using a New Flow Model of Crystallization. 
Scanning Microscopy, 9, 2, 577-586. 
Al-Kattan, A.; Dufour, P.; Dexpert-Ghys, J. & Drouet, C. (2010). Preparation and 
Physicochemical Characteristics of Luminescent Apatite-Based Colloids. Journal of 
Physical Chemistry C, 114, 7, 2918-2924. 
Alam, M. I.; Asahina, I.; Ohmamiuda, K.; Takahashi, K.; Yokota, S. & Enomoto, S. (2001). 
Evaluation of ceramics composed of different hydroxyapatite to tricalcium 
phosphate ratios as carriers for rhBMP-2. Biomaterials, 22, 12, 1643-51. 
Araiza, M. A.; Gomez-Morales, J.; Clemente, R. R. & Castano, V. M. (1999). Conversion of 
the echinoderm Mellita eduardobarrosoi calcite skeleton into porous 
hydroxyapatite by treatment with phosphated boiling solutions. Journal of Materials 
Synthesis and Processing, 7, 4, 211-219. 
Arsenault, A. L. & Robinson, B. W. (1989). The Dentino-Enamel Junction - a Structural and 
Microanalytical Study of Early Mineralization. Calcified Tissue International, 45, 2, 
111-121. 
Autefage, H.; Briand-Mesange, F.; Cazalbou, S.; Drouet, C.; Fourmy, D.; Goncalves, S.; 
Salles, J. P.; Combes, C.; Swider, P. & Rey, C. (2009). Adsorption and Release of 
BMP-2 on Nanocrystalline Apatite-Coated and Uncoated Hydroxyapatite/beta-
Tricalcium Phosphate Porous Ceramics. Journal of Biomedical Materials Research Part 
B-Applied Biomaterials, 91B, 2, 706-715. 
Barroug, A.; Kuhn, L. T.; Gerstenfeld, L. C. & Glimcher, M. J. (2004). Interactions of cisplatin 
with calcium phosphate nanoparticles: in vitro controlled adsorption and release. J 
Orthop Res, 22, 4, 703-8. 
Ben-Nissan, B. & Choi, A. H. (2006). Sol-gel production of bioactive nanocoatings for 
medical applications. Part 1: an introduction. Nanomedicine, 1, 3, 311-319. 
Bertassoni, L. E.; Habelitz, S.; Kinney, J. H.; Marshall, S. J. & Marshall, G. W. (2009). 
Biomechanical Perspective on the Remineralization of Dentin. Caries Research, 43, 1, 
70-77. 
Bigi, A.; Compostella, L.; Fichera, A. M.; Foresti, E.; Gazzano, M.; Ripamonti, A. & Roveri, N. 
(1988). Structural and chemical characterization of inorganic deposits in calcified 
human mitral valve. J Inorg Biochem, 34, 2, 75-82. 
Bigi, A.; Gandolfi, M.; Koch, M. H. & Roveri, N. (1996). X-ray diffraction study of in vitro 
calcification of tendon collagen. Biomaterials, 17, 12, 1195-201. 
Bigi, A.; Gandolfi, M.; Roveri, N. & Valdre, G. (1997). In vitro calcified tendon collagen: an 
atomic force and scanning electron microscopy investigation. Biomaterials, 18, 9, 
657-65. 
Bigi, A.; Ripamonti, A.; Cojazzi, G.; Pizzuto, G.; Roveri, N. & Koch, M. H. (1991). Structural 
analysis of turkey tendon collagen upon removal of the inorganic phase. Int J Biol 
Macromol, 13, 2, 110-4. 
Boix, T.; Gomez-Morales, J.; Torrent-Burgues, J.; Monfort, A.; Puigdomenech, P. & 
Rodriguez-Clemente, R. (2005). Adsorption of recombinant human bone 
morphogenetic protein rhBMP-2m onto hydroxyapatite. J Inorg Biochem, 99, 5, 1043-
50. 
www.intechopen.com
The Biomimetic Approach to Design Apatites for Nanobiotechnological Applications   
 
95 
Boskey, A. L. (2007). Mineralization of bones and teeth. Elements, 3, 6, 385-391. 
Brancaccio, D. & Cozzolino, M. (2005). The mechanism of calcium deposition in soft tissues. 
Contrib Nephrol, 149, 279-86. 
Burger, C.; Zhou, H. W.; Wang, H.; Sics, I.; Hsiao, B. S.; Chu, B.; Graham, L. & Glimcher, M. 
J. (2008). Lateral packing of mineral crystals in bone collagen fibrils. Biophysical 
Journal, 95, 4, 1985-1992. 
Cazalbou, S.; Combes, C.; Eichert, D.; Rey, C. & Glimcher, M. J. (2004). Poorly crystalline 
apatites: evolution and maturation in vitro and in vivo. Journal of Bone and Mineral 
Metabolism, 22, 4, 310-317. 
Cazalbou, S.; Eichert, D.; Ranz, X.; Drouet, C.; Combes, C.; Harmand, M. F. & Rey, C. (2005). 
Ion exchanges in apatites for biomedical application. Journal of Materials Science-
Materials in Medicine, 16, 5, 405-409. 
Chai, C. S. & Ben-Nissan, B. (1999). Bioactive nanocrystalline sol-gel hydroxyapatite 
coatings. Journal of Materials Science-Materials in Medicine, 10, 8, 465-469. 
Charriere, E.; Lemaitre, J. & Zysset, P. (2003). Hydroxyapatite cement scaffolds with 
controlled macroporosity: fabrication protocol and mechanical properties. 
Biomaterials, 24, 5, 809-817. 
Chaudhry, A. A.; Haque, S.; Kellici, S.; Boldrin, P.; Rehman, I.; Fazal, A. K. & Darr, J. A. 
(2006). Instant nano-hydroxyapatite: a continuous and rapid hydrothermal 
synthesis. Chemical Communications, 21, 2286-2288. 
Chevalier, E.; Chulia, D.; Pouget, C. & Viana, M. (2008). Fabrication of porous substrates: A 
review of processes using pore forming agents in the biomaterial field. Journal of 
Pharmaceutical Sciences, 97, 3, 1135-1154. 
Choi, A. H. & Ben-Nissan, B. (2007). Sol-gel production of bioactive nanocoatings for 
medical applications. Part II: current research and development. Nanomedicine, 2, 1, 
51-61. 
Cowles, E. A.; DeRome, M. E.; Pastizzo, G.; Brailey, L. L. & Gronowicz, G. A. (1998). 
Mineralization and the expression of matrix proteins during in vivo bone 
development. Calcified Tissue International, 62, 1, 74-82. 
Cui, F. Z. & Ge, J. (2007). New observations of the hierarchical structure of human enamel, 
from nanoscale to microscale. Journal of Tissue Engineering and Regenerative Medicine, 
1, 3, 185-191. 
Cui, F. Z.; Li, Y. & Ge, J. (2007). Self-assembly of mineralized collagen composites. Materials 
Science & Engineering R-Reports, 57, 1-6, 1-27. 
Cushing, B. L.; Kolesnichenko, V. L. & O'Connor, C. J. (2004). Recent advances in the liquid-
phase syntheses of inorganic nanoparticles. Chemical Reviews, 104, 9, 3893-3946. 
Daculsi, G.; Bouler, J. M. & LeGeros, R. Z. (1997). Adaptive crystal formation in normal and 
pathological calcifications in synthetic calcium phosphate and related biomaterials. 
International Review of Cytology - a Survey of Cell Biology, Vol 172, 172, 129-191. 
de Groot, K. (1993). Clinical applications of calcium phosphate biomaterials: A review. 
Ceramics International, 19, 5, 363-366. 
Dorozhkin, S. V. (2009). Calcium orthophosphate-based biocomposites and hybrid 
biomaterials. Journal of Materials Science, 44, 9, 2343-2387. 
Dorozhkin, S. V. (2010). Bioceramics of calcium orthophosphates. Biomaterials, 31, 7, 1465-85. 
www.intechopen.com
 Advances in Biomimetics 
 
96 
Drouet, C.; Bosc, F.; Banu, M.; Largeot, C.; Combes, C.; Dechambre, G.; Estournes, C.; 
Raimbeaux, G. & Rey, C. (2009). Nanocrystalline apatites: From powders to 
biomaterials. Powder Technology, 190, 1-2, 118-122. 
Eichert, C.; Drouet, C.; Sfihi, H.; Rey, C. & Combes, C. (2007). Nanocrystalline apatite-based 
biomaterials: synthesis, processing and characterization. In Biomaterials Research 
Advances, ed. J. Kendall, 93-143. Nova Science Publishers. 
Epple, M.; Ganesan, K.; Heumann, R.; Klesing, J.; Kovtun, A.; Neumann, S. & Sokolova, V. 
(2010). Application of calcium phosphate nanoparticles in biomedicine. Journal of 
Materials Chemistry, 20, 1, 18-23. 
Errassif, F.; Menbaoui, A.; Autefage, H.; Benaziz, L.; Ouizat, S.; Santran, V.; Sarda, S.; 
Lebugle, A.; Combes, C.; Barroug, A.; Sfihi, H. & Rey, C. 2010. Adsorption on 
Apatitic Calcium Phosphates: Applications to Drug Delivery In Advances in 
Bioceramics and Biotechnologies, eds. R. Narayan, M. Singh & J. McKittrick. Wiley-
VCH Verlag GmbH & Co. KGaA  
Feng, J. Q.; Ward, L. M.; Liu, S.; Lu, Y.; Xie, Y.; Yuan, B.; Yu, X.; Rauch, F.; Davis, S. I.; Zhang, 
S.; Rios, H.; Drezner, M. K.; Quarles, L. D.; Bonewald, L. F. & White, K. E. (2006). 
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in 
mineral metabolism. Nat Genet, 38, 11, 1310-5. 
Fernandez-Moran, H. & Engstrom, A. (1957). Electron microscopy and x-ray diffraction of 
bone. Biochim Biophys Acta, 23, 2, 260-4. 
Fratzl, P.; Gupta, H. S.; Paschalis, E. P. & Roschger, P. (2004). Structure and mechanical 
quality of the collagen-mineral nano-composite in bone. Journal of Materials 
Chemistry, 14, 14, 2115-2123. 
Ganesan, K. & Epple, M. (2008). Calcium phosphate nanoparticles as nuclei for the 
preparation of colloidal calcium phytate. New Journal of Chemistry, 32, 8, 1326-1330. 
Gautier, H.; Daculsi, G. & Merle, C. (2001). Association of vancomycin and calcium 
phosphate by dynamic compaction: in vitro characterization and microbiological 
activity. Biomaterials, 22, 18, 2481-7. 
Gautier, H.; Merle, C.; Auget, J. L. & Daculsi, G. (2000). Isostatic compression, a new process 
for incorporating vancomycin into biphasic calcium phosphate: comparison with a 
classical method. Biomaterials, 21, 3, 243-249. 
Gonzalez-McQuire, R.; Green, D.; Walsh, D.; Hall, S.; Chane-Ching, J. Y.; Oreffo, R. O. C. & 
Mann, S. (2005). Fabrication of hydroxyapatite sponges by dextran sulphate/amino 
acid templating. Biomaterials, 26, 33, 6652-6656. 
Guo, X.; Gough, J. E.; Xiao, P.; Liu, J. & Shen, Z. (2007). Fabrication of nanostructured 
hydroxyapatite and analysis of human osteoblastic cellular response. J Biomed Mater 
Res A, 82, 4, 1022-32. 
Hannig, C.; Berndt, D.; Hoth-Hannig, W. & Hannig, M. (2009). The effect of acidic beverages 
on the ultrastructure of the acquired pellicle--an in situ study. Arch Oral Biol, 54, 6, 
518-26. 
Hannig, M. & Hannig, C. (2010). Nanomaterials in preventive dentistry. Nature 
Nanotechnology, 5, 8, 565-569. 
Hayashizaki, J.; Ban, S.; Nakagaki, H.; Okumura, A.; Yoshii, S. & Robinson, C. (2008). Site 
specific mineral composition and microstructure of human supra-gingival dental 
calculus. Archives of Oral Biology, 53, 2, 168-174. 
www.intechopen.com
The Biomimetic Approach to Design Apatites for Nanobiotechnological Applications   
 
97 
Hong, J.-Y.; Kim, Y. J.; Lee, H.-W.; Lee, W.-K.; Ko, J. S. & Kim, H.-M. (2003). Osteoblastic cell 
response to thin film of poorly crystalline calcium phosphate apatite formed at low 
temperatures. Biomaterials, 24, 18, 2977-2984. 
Huang, J.; Best, S. M.; Bonfield, W.; Brooks, R. A.; Rushton, N.; Jayasinghe, S. N. & 
Edirisinghe, M. J. (2004). In vitro assessment of the biological response to nano-
sized hydroxyapatite. Journal of Materials Science-Materials in Medicine, 15, 4, 441-
445. 
Iafisco, M.; Marchetti, M.; Morales, J. G.; Hernandez-Hernandez, M. A.; Ruiz, J. M. G. & 
Roveri, N. (2009a). Silica Gel Template for Calcium Phosphates Crystallization. 
Crystal Growth & Design, 9, 11, 4912-4921. 
Iafisco, M.; Morales, J. G.; Hernandez-Hernandez, M. A.; Garcia-Ruiz, J. M. & Roveri, N. 
(2010a). Biomimetic Carbonate-Hydroxyapatite Nanocrystals Prepared by Vapor 
Diffusion. Advanced Engineering Materials, 12, 7, B218-B223. 
Iafisco, M.; Palazzo, B.; Falini, G.; Di Foggia, M.; Bonora, S.; Nicolis, S.; Casella, L. & Roveri, 
N. (2008). Adsorption and conformational change of myoglobin on biomimetic 
hydroxyapatite nanocrystals functionalized with alendronate. Langmuir, 24, 9, 4924-
4930. 
Iafisco, M.; Palazzo, B.; Marchetti, M.; Margiotta, N.; Ostuni, R.; Natile, G.; Morpurgo, M.; 
Gandin, V.; Marzano, C. & Roveri, N. (2009b). Smart delivery of antitumoral 
platinum complexes from biomimetic hydroxyapatite nanocrystals. Journal of 
Materials Chemistry, 19, 44, 8385-8392. 
Iafisco, M.; Sabatino, P.; Lesci, I. G.; Prat, M.; Rimondini, L. & Roveri, N. (2010b). 
Conformational modifications of serum albumins adsorbed on different kinds of 
biomimetic hydroxyapatite nanocrystals. Colloids Surf B Biointerfaces, 81, 1, 274-84. 
Imbeni, V.; Kruzic, J. J.; Marshall, G. W.; Marshall, S. J. & Ritchie, R. O. (2005). The dentin-
enamel junction and the fracture of human teeth. Nature Materials, 4, 3, 229-232. 
Karageorgiou, V. & Kaplan, D. (2005). Porosity of 3D biomaterial scaffolds and osteogenesis. 
Biomaterials, 26, 27, 5474-91. 
Kazama, J. J.; Amizuka, N. & Fukagawa, M. (2006). Ectopic calcification as abnormal 
biomineralization. Therapeutic Apheresis and Dialysis, 10, S34-S38. 
Kirsch, T. (2006). Determinants of pathological mineralization. Curr Opin Rheumatol, 18, 2, 
174-80. 
Kodaka, T.; Nakajima, F. & Higashi, S. (1989). Structure of the So-Called Prismless Enamel in 
Human Deciduous Teeth. Caries Research, 23, 5, 290-296. 
Koutsopoulos, S. (2002). Synthesis and characterization of hydroxyapatite crystals: a review 
study on the analytical methods. J Biomed Mater Res, 62, 4, 600-12. 
Laird, D. F.; Mucalo, M. R. & Yokogawa, Y. (2006). Growth of calcium hydroxyapatite (Ca-
HAp) on cholesterol and cholestanol crystals from a simulated body fluid: A 
possible insight into the pathological calcifications associated with atherosclerosis. 
Journal of Colloid and Interface Science, 295, 2, 348-363. 
Layrolle, P. & Lebugle, A. (1994). Characterization and Reactivity of Nanosized Calcium 
Phosphates Prepared in Anhydrous Ethanol. Chemistry of Materials, 6, 11, 1996-2004. 
Lebugle, A.; Rodrigues, A.; Bonnevialle, P.; Voigt, J. J.; Canal, P. & Rodriguez, F. (2002). 
Study of implantable calcium phosphate systems for the slow release of 
methotrexate. Biomaterials, 23, 16, 3517-22. 
www.intechopen.com
 Advances in Biomimetics 
 
98 
LeGeros, R. Z. (2008). Calcium Phosphate-Based Osteoinductive Materials. Chemical Reviews, 
108, 11, 4742-4753. 
Legeros, R. Z. & Craig, R. G. (1993). Strategies to Affect Bone Remodeling - Osteointegration. 
Journal of Bone and Mineral Research, 8, S583-S596. 
Legeros, R. Z.; Orly, I.; Legeros, J. P.; Gomez, C.; Kazimiroff, J.; Tarpley, T. & Kerebel, B. 
(1988). Scanning Electron-Microscopy and Electron-Probe Microanalyses of the 
Crystalline Components of Human and Animal Dental Calculi. Scanning 
Microscopy, 2, 1, 345-356. 
Legros, R.; Balmain, N. & Bonel, G. (1987). Age-related changes in mineral of rat and bovine 
cortical bone. Calcif Tissue Int, 41, 3, 137-44. 
Li, L.; Pan, H.; Tao, J.; Xu, X.; Mao, C.; Gu, X. & Tang, R. (2008). Repair of enamel by using 
hydroxyapatite nanoparticles as the building blocks. Journal of Materials Chemistry, 
18, 34, 4079-4084. 
Li, X. F.; Fan, T. X.; Liu, Z. T.; Ding, J.; Guo, Q. X. & Zhang, D. (2006). Synthesis and 
hierarchical pore structure of biomorphic manganese oxide derived from woods. 
Journal of the European Ceramic Society, 26, 16, 3657-3664. 
Liou, S. C.; Chen, S. Y.; Lee, H. Y. & Bow, J. S. (2004). Structural characterization of nano-
sized calcium deficient apatite powders. Biomaterials, 25, 2, 189-196. 
Liu, D. M. (1997). Fabrication of hydroxyapatite ceramic with controlled porosity. Journal of 
Materials Science-Materials in Medicine, 8, 4, 227-232. 
Liu, J. B.; Li, K. W.; Wang, H.; Zhu, M. K.; Xu, H. Y. & Yan, H. (2005). Self-assembly of 
hydroxyapatite nanostructures by microwave irradiation. Nanotechnology, 16, 1, 82-
87. 
Liu, Y. L.; Enggist, L.; Kuffer, A. F.; Buser, D. & Hunziker, E. B. (2007). The influence of 
BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces 
during the early phase of osseointegration (vol 28, pg 2677, 2007). Biomaterials, 28, 
35, 5399-5399. 
Lopez-Macipe, A.; Gomez-Morales, J. & Rodriguez-Clemente, R. (1998). Nanosized 
hydroxyapatite precipitation from homogeneous calcium/citrate/phosphate 
solutions using microwave and conventional heating. Advanced Materials, 10, 1, 49-
+. 
Loveridge, N. (1999). Bone: More than a stick. Journal of Animal Science, 77, 190-196. 
Lu, J. X.; Flautre, B.; Anselme, K.; Hardouin, P.; Gallur, A.; Descamps, M. & Thierry, B. 
(1999). Role of interconnections in porous bioceramics on bone recolonization in 
vitro and in vivo. Journal of Materials Science-Materials in Medicine, 10, 2, 111-120. 
Mann, S.; Archibald, D. D.; Didymus, J. M.; Douglas, T.; Heywood, B. R.; Meldrum, F. C. & 
Reeves, N. J. (1993). Crystallization at Inorganic-organic Interfaces: Biominerals and 
Biomimetic Synthesis. Science, 261, 5126, 1286-92. 
Manolagas, S. C. (2000). Birth and death of bone cells: Basic regulatory mechanisms and 
implications for the pathogenesis and treatment of osteoporosis. Journal of Aging 
and Physical Activity, 8, 3, 248-248. 
Mao, Y.; Park, T. J.; Zhang, F.; Zhou, H. & Wong, S. S. (2007). Environmentally friendly 
methodologies of nanostructure synthesis. Small, 3, 7, 1122-1139. 
Marra, S. P.; Daghlian, C. P.; Fillinger, M. F. & Kennedy, F. E. (2006). Elemental composition, 
morphology and mechanical properties of calcified deposits obtained from 
abdominal aortic aneurysms. Acta Biomaterialia, 2, 5, 515-520. 
www.intechopen.com
The Biomimetic Approach to Design Apatites for Nanobiotechnological Applications   
 
99 
Mastrogiacomo, M.; Scaglione, S.; Martinetti, R.; Dolcini, L.; Beltrame, F.; Cancedda, R. & 
Quarto, R. (2006). Role of scaffold internal structure on in vivo bone formation in 
macroporous calcium phosphate bioceramics. Biomaterials, 27, 17, 3230-3237. 
McLeod, K.; Kumar, S.; Smart, R. S. C.; Dutta, N.; Voelcker, N. H.; Anderson, G. I. & Sekel, 
R. (2006). XPS and bioactivity study of the bisphosphonate pamidronate adsorbed 
onto plasma sprayed hydroxyapatite coatings. Applied Surface Science, 253, 5, 2644-
2651. 
Midy, V.; Hollande, E.; Rey, C.; Dard, M. & Plouet, J. (2001). Adsorption of vascular 
endothelial growth factor to two different apatitic materials and its release. J Mater 
Sci Mater Med, 12, 4, 293-8. 
Nakashima, S.; Yoshie, M.; Sano, H. & Bahar, A. (2009). Effect of a test dentifrice containing 
nano-sized calcium carbonate on remineralization of enamel lesions in vitro. Journal 
of oral science, 51, 1, 69-77. 
Olszta, M. J.; Cheng, X. G.; Jee, S. S.; Kumar, R.; Kim, Y. Y.; Kaufman, M. J.; Douglas, E. P. & 
Gower, L. B. (2007). Bone structure and formation: A new perspective. Materials 
Science & Engineering R-Reports, 58, 3-5, 77-116. 
Orsini, G.; Procaccini, M.; Manzoli, L.; Giuliodori, F.; Lorenzini, A. & Putignano, A. (2010). A 
double-blind randomized-controlled trial comparing the desensitizing efficacy of a 
new dentifrice containing carbonate/hydroxyapatite nanocrystals and a sodium 
fluoride/potassium nitrate dentifrice. Journal of Clinical Periodontology, 37, 6, 510-
517. 
Paine, M. L.; White, S. N.; Luo, W.; Fong, H.; Sarikaya, M. & Snead, M. L. (2001). Regulated 
gene expression dictates enamel structure and tooth function. Matrix Biology, 20, 5-
6, 273-292. 
Palazzo, B.; Iafisco, M.; Laforgia, M.; Margiotta, N.; Natile, G.; Bianchi, C. L.; Walsh, D.; 
Mann, S. & Roveri, N. (2007). Biomimetic hydroxyapatite-drug nanocrystals as 
potential bone substitutes with antitumor drug delivery properties. Advanced 
Functional Materials, 17, 13, 2180-2188. 
Palazzo, B.; Sidoti, M. C.; Roveri, N.; Tampieri, A.; Sandri, M.; Bertolazzi, L.; Galbusera, F.; 
Dubini, G.; Vena, P. & Contro, R. (2005). Controlled drug delivery from porous 
hydroxyapatite grafts: An experimental and theoretical approach. Materials Science 
& Engineering C-Biomimetic and Supramolecular Systems, 25, 2, 207-213. 
Palazzo, B.; Walsh, D.; Iafisco, M.; Foresti, E.; Bertinetti, L.; Martra, G.; Bianchi, C. L.; 
Cappelletti, G. & Roveri, N. (2009). Amino acid synergetic effect on structure, 
morphology and surface properties of biomimetic apatite nanocrystals. Acta 
Biomater, 5, 4, 1241-52. 
Palmer, L. C.; Newcomb, C. J.; Kaltz, S. R.; Spoerke, E. D. & Stupp, S. I. (2008). Biomimetic 
systems for hydroxyapatite mineralization inspired by bone and enamel. Chemical 
Reviews, 108, 11, 4754-83. 
Paschalis, E. P.; DiCarlo, E.; Betts, F.; Sherman, P.; Mendelsohn, R. & Boskey, A. L. (1996). 
FTIR microspectroscopic analysis of human osteonal bone. Calcified Tissue 
International, 59, 6, 480-487. 
Peter, B.; Pioletti, D. P.; Laib, S.; Bujoli, B.; Pilet, P.; Janvier, P.; Guicheux, J.; Zambelli, P. Y.; 
Bouler, J. M. & Gauthier, O. (2005). Calcium phosphate drug delivery system: 
influence of local zoledronate release on bone implant osteointegration. Bone, 36, 1, 
52-60. 
www.intechopen.com
 Advances in Biomimetics 
 
100 
Phillips, M. J.; Darr, J. A.; Luklinska, Z. B. & Rehman, I. (2003). Synthesis and 
characterization of nano-biomaterials with potential osteological applications. 
Journal of Materials Science-Materials in Medicine, 14, 10, 875-882. 
Puleo, D. A. (2004). Bone–Implant Interface. Encyclopedia of Biomaterials and Biomedical 
Engineering, 190 - 198. 
Rameshbabu, N.; Rao, K. P. & Kumar, T. S. S. (2005). Acclerated microwave processing of 
nanocrystalline hydroxyapatite. Journal of Materials Science, 40, 23, 6319-6323. 
Reddi, A. H. (1994). Symbiosis of Biotechnology and Biomaterials - Applications in Tissue 
Engineering of Bone and Cartilage. Journal of Cellular Biochemistry, 56, 2, 192-195. 
Rey, C.; Collins, B.; Goehl, T.; Dickson, I. R. & Glimcher, M. J. (1989). The Carbonate 
Environment in Bone-Mineral - a Resolution-Enhanced Fourier-Transform 
Infrared-Spectroscopy Study. Calcified Tissue International, 45, 3, 157-164. 
Rey, C.; Shimizu, M.; Collins, B. & Glimcher, M. J. (1990). Resolution-enhanced Fourier 
transform infrared spectroscopy study of the environment of phosphate ions in the 
early deposits of a solid phase of calcium-phosphate in bone and enamel, and their 
evolution with age. I: Investigations in the upsilon 4 PO4 domain. Calcif Tissue Int, 
46, 6, 384-94. 
Rodriguez-Lorenzo, L. M.; Vallet-Regi, M. & Ferreira, J. M. (2001). Fabrication of 
hydroxyapatite bodies by uniaxial pressing from a precipitated powder. 
Biomaterials, 22, 6, 583-8. 
Roveri, N.; Battistella, E.; Bianchi, C. L.; Foltran, I.; Foresti, E.; Iafisco, M.; Lelli, M.; Naldoni, 
A.; Palazzo, B. & Rimondini, L. (2009). Surface Enamel Remineralization: 
Biomimetic Apatite Nanocrystals and Fluoride Ions Different Effects. Journal of 
Nanomaterials, -. 
Roveri, N.; Battistella, E.; Foltran, I.; Foresti, E.; Iafisco, M.; Lelli, M.; Palazzo, B. & 
Rimondini, L. (2008a). Synthetic Biomimetic Carbonate-Hydroxyapatite 
Nanocrystals for Enamel Remineralization. Advanced Materials Research, 47-50, 821-
824. 
Roveri, N.; Palazzo, B. & Iafisco, M. (2008b). The role of biomimetism in developing 
nanostructured inorganic matrices for drug delivery. Expert Opinion on Drug 
Delivery, 5, 8, 861-877. 
Sader, M.; LeGeros, R. & Soares, G. (2009). Human osteoblasts adhesion and proliferation on 
magnesium-substituted tricalcium phosphate dense tablets. Journal of Materials 
Science: Materials in Medicine, 20, 2, 521-527. 
Sakhno, Y.; Bertinetti, L.; Iafisco, M.; Tampieri, A.; Roveri, N. & Martra, G. (2010). Surface 
Hydration and Cationic Sites of Nanohydroxyapatites with Amorphous or 
Crystalline Surfaces: A Comparative Study. The Journal of Physical Chemistry C, 114, 
39, 16640-16648. 
Sanchez, C.; Arribart, H. & Guille, M. M. G. (2005). Biomimetism and bioinspiration as tools 
for the design of innovative materials and systems. Nature Materials, 4, 4, 277-288. 
Sarikaya, M.; Tamerler, C.; Jen, A. K.; Schulten, K. & Baneyx, F. (2003). Molecular 
biomimetics: nanotechnology through biology. Nature Materials, 2, 9, 577-85. 
Schmidt, H. K. (2000). Nanoparticles for ceramic and nanocomposite processing. Molecular 
Crystals and Liquid Crystals, 353, 165-179. 
www.intechopen.com
The Biomimetic Approach to Design Apatites for Nanobiotechnological Applications   
 
101 
Shibata, Y.; He, L. H.; Kataoka, Y.; Miyazaki, T. & Swain, M. V. (2008). Micromechanical 
property recovery of human carious dentin achieved with colloidal nano-beta-
tricalcium phosphate. J Dent Res, 87, 3, 233-7. 
Singh, M.; Martinez-Fernandez, J. & de Arellano-Lopez, A. R. (2003). Environmentally 
conscious ceramics (ecoceramics) from natural wood precursors. Current Opinion in 
Solid State & Materials Science, 7, 3, 247-254. 
Siva Rama Krishna, D.; Siddharthan, A.; Seshadri, S. K. & Sampath Kumar, T. S. (2007). A 
novel route for synthesis of nanocrystalline hydroxyapatite from eggshell waste. J 
Mater Sci Mater Med, 18, 9, 1735-43. 
Sopyan, I.; Mel, M.; Ramesh, S. & Khalid, K. A. (2007). Porous hydroxyapatite for artificial 
bone applications. Science and Technology of Advanced Materials, 8, 1-2, 116-123. 
Stigter, M.; Bezemer, J.; de Groot, K. & Layrolle, P. (2004). Incorporation of different 
antibiotics into carbonated hydroxyapatite coatings on titanium implants, release 
and antibiotic efficacy. J Control Release, 99, 1, 127-37. 
Sun, W. B.; Chu, C. L.; Wang, J. & Zhao, H. T. (2007). Comparison of periodontal ligament 
cells responses to dense and nanophase hydroxyapatite. Journal of Materials Science-
Materials in Medicine, 18, 5, 677-683. 
Tamerler, C. & Sarikaya, M. (2007). Molecular biomimetics: utilizing nature's molecular 
ways in practical engineering. Acta Biomater, 3, 3, 289-99. 
Tamerler, C. & Sarikaya, M. (2008). Molecular biomimetics: Genetic synthesis, assembly, and 
formation of materials using peptides. Mrs Bulletin, 33, 5, 504-510. 
Tampieri, A.; Sprio, S.; Ruffini, A.; Celotti, G.; Lesci, I. G. & Roveri, N. (2009). From wood to 
bone: multi-step process to convert wood hierarchical structures into biomimetic 
hydroxyapatite scaffolds for bone tissue engineering. Journal of Materials Chemistry, 
19, 28, 4973-4980. 
Tancret, F.; Bouler, J. M.; Chamousset, J. & Minois, L. M. (2006). Modelling the mechanical 
properties of microporous and macroporous biphasic calcium phosphate 
bioceramics. Journal of the European Ceramic Society, 26, 16, 3647-3656. 
Tas, A. C. (2000). Synthesis of biomimetic Ca-hydroxyapatite powders at 37 degrees C in 
synthetic body fluids. Biomaterials, 21, 14, 1429-1438. 
Termine, J. D.; Kleinman, H. K.; Whitson, S. W.; Conn, K. M.; McGarvey, M. L. & Martin, G. 
R. (1981). Osteonectin, a bone-specific protein linking mineral to collagen. Cell, 26, 1 
Pt 1, 99-105. 
Traub, W.; Arad, T. & Weiner, S. (1989). Three-dimensional ordered distribution of crystals 
in turkey tendon collagen fibers. Proc Natl Acad Sci U S A, 86, 24, 9822-6. 
Tzaphlidou, M. (2008). Bone Architecture: Collagen Structure and Calcium/Phosphorus 
Maps. Journal of Biological Physics, 34, 1-2, 39-49. 
Urist, M. R. (2002). Bone: Formation by autoinduction (Reprinted from Science, vol 150, pg 
893-899, 1965). Clinical Orthopaedics and Related Research, 395, 5-10. 
Vollenweider, M.; Brunner, T. J.; Knecht, S.; Grass, R. N.; Zehnder, M.; Imfeld, T. & Stark, W. 
J. (2007). Remineralization of human dentin using ultrafine bioactive glass particles. 
Acta Biomater, 3, 6, 936-43. 
Vriezema, D. M.; Aragonès, M. C.; Elemans, J. A. A. W.; Cornelissen, J. J. L. M.; Rowan, A. E. 
& Nolte, R. J. M. (2005). Self-assembled nanoreactors. Chemical Reviews, 105, 4, 1445-
1489. 
www.intechopen.com
 Advances in Biomimetics 
 
102 
Wahl, D. A. & Czernuszka, J. T. (2006). Collagen-hydroxyapatite composites for hard tissue 
repair. European Cells & Materials, 11, 43-56. 
Walsh, D.; Boanini, E.; Tanaka, J. & Mann, S. (2005). Synthesis of tri-calcium phosphate 
sponges by interfacial deposition and thermal transformation of self-supporting 
calcium phosphate films. Journal of Materials Chemistry, 15, 10, 1043-1048. 
Walsh, D. & Tanaka, J. (2001). Preparation of a bone-like apatite foam cement. Journal of 
Materials Science-Materials in Medicine, 12, 4, 339-343. 
Wang, J. W. & Shaw, L. L. (2007). Morphology-enhanced low-temperature sintering of 
nanocrystalline hydroxyapatite. Advanced Materials, 19, 17, 2364-+. 
Wang, R. Z. & Weiner, S. (1998). Strain-structure relations in human teeth using Moire 
fringes. Journal of Biomechanics, 31, 2, 135-141. 
Wang, X.; Zhuang, J.; Peng, Q. & Li, Y. D. (2005). A general strategy for nanocrystal 
synthesis. Nature, 437, 7055, 121-124. 
Weiner, S. & Addadi, L. (1997). Design strategies in mineralized biological materials. Journal 
of Materials Chemistry, 7, 5, 689-702. 
Weiner, S. & Wagner, H. D. (1998). The material bone: Structure mechanical function 
relations. Annual Review of Materials Science, 28, 271-298. 
Weissen-Plenz, G.; Nitschke, Y. & Rutsch, F. (2008). Mechanisms of Arterial Calcification: 
Spotlight on the Inhibitors. Advances in Clinical Chemistry, Vol 46, 46, 263-293. 
Wen, H. B.; Moradian-Oldak, J. & Fincham, A. G. (2000). Dose-dependent modulation of 
octacalcium phosphate crystal habit by amelogenins. Journal of Dental Research, 79, 
11, 1902-1906. 
Wesson, J. A. & Ward, M. D. (2007). Pathological biomineralization of kidney stones. 
Elements, 3, 6, 415-421. 
White, S. N.; Luo, W.; Paine, M. L.; Fong, H.; Sarikaya, M. & Snead, M. L. (2001). Biological 
organization of hydroxyapatite crystallites into a fibrous continuum toughens and 
controls anisotropy in human enamel. Journal of Dental Research, 80, 1, 321-326. 
Whittaker, D. K. (1982). Structural variations in the surface zone of human tooth enamel 
observed by scanning electron microscopy. Archives of Oral Biology, 27, 5, 383-92. 
Wozney, J. M. (1992). The Bone Morphogenetic Protein Family and Osteogenesis. Molecular 
Reproduction and Development, 32, 2, 160-167. 
Ye, F.; Guo, H. F. & Zhang, H. J. (2008). Biomimetic synthesis of oriented hydroxyapatite 
mediated by nonionic surfactants. Nanotechnology, 19, 24, -. 
Yeon, K. C.; Wang, J. & Ng, S. C. (2001). Mechanochemical synthesis of nanocrystalline 
hydroxyapatite from CaO and CaHPO4. Biomaterials, 22, 20, 2705-12. 
Yoshinari, M.; Oda, Y.; Ueki, H. & Yokose, S. (2001). Immobilization of bisphosphonates on 
surface modified titanium. Biomaterials, 22, 7, 709-715. 
Zhang, Y. J. & Lu, J. J. (2007). A simple method to tailor spherical nanocrystal 
hydroxyapatite at low temperature. Journal of Nanoparticle Research, 9, 4, 589-594. 
Zimmerman, A. F.; Palumbo, G.; Aust, K. T. & Erb, U. (2002). Mechanical properties of 
nickel silicon carbide nanocomposites. Materials Science and Engineering a-Structural 
Materials Properties Microstructure and Processing, 328, 1-2, 137-146. 
 
 
www.intechopen.com
Advances in Biomimetics
Edited by Prof. Marko Cavrak
ISBN 978-953-307-191-6
Hard cover, 522 pages
Publisher InTech
Published online 26, April, 2011
Published in print edition April, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The interaction between cells, tissues and biomaterial surfaces are the highlights of the book "Advances in
Biomimetics". In this regard the effect of nanostructures and nanotopographies and their effect on the
development of a new generation of biomaterials including advanced multifunctional scaffolds for tissue
engineering are discussed. The 2 volumes contain articles that cover a wide spectrum of subject matter such
as different aspects of the development of scaffolds and coatings with enhanced performance and bioactivity,
including investigations of material surface-cell interactions.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Norberto Roveri and Michele Iafisco (2011). The Biomimetic Approach to Design Apatites for
Nanobiotechnological Applications, Advances in Biomimetics, Prof. Marko Cavrak (Ed.), ISBN: 978-953-307-
191-6, InTech, Available from: http://www.intechopen.com/books/advances-in-biomimetics/the-biomimetic-
approach-to-design-apatites-for-nanobiotechnological-applications
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
